Chemours reported a strong second quarter in 2021, with net sales of $1.7 billion, a 51% increase year-over-year. Net income was $66 million, with an EPS of $0.39. Adjusted EBITDA was $366 million, up 120% year-over-year, and free cash flow was $189 million, an increase of $139 million year-over-year.
Net Sales of $1.7 billion, up 51% year-over-year
Net Income of $66 million with EPS of $0.39
Adjusted Net Income of $205 million with Adjusted EPS of $1.20, up $1.02 year-over-year
Free cash flow of $189 million, an increase of $139 million year-over-year
Given strong second quarter results and continued business momentum, Chemours now expects 2021 Adjusted EBITDA and Adjusted EPS to be in the top end of its guidance ranges.
Analyze how earnings announcements historically affect stock price performance